ceralasertib,nivolumab,topotecan,lirilumab,irinotecan,olaparib,ribociclib,carboplatin,temozolomide,enasidenib,adavosertib
merck,innate,bms,novartis,servier,astrazeneca
['cam ', 'esmart']
today, phase 1 results from the esmart trial were presented at #aacr23. so pleased to hear how a new drug combination could treat various paediatric cancers. an exciting first step in this trial, which could have a positive impact on children and young people with cancer #tyacam 
Chief Executive at Cancer Research UK @CR_UK. Views my own.